STOCK TITAN

Akanda Corp - AKAN STOCK NEWS

Welcome to our dedicated news page for Akanda (Ticker: AKAN), a resource for investors and traders seeking the latest updates and insights on Akanda.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Akanda's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Akanda's position in the market.

Rhea-AI Summary
Akanda Corp. announces a pause in equity financings for 30 days to evaluate strategic investments in international cannabis and technology markets. The company completed public offerings totaling $5,983,000 and eliminated $4M of debt with the sale of its subsidiary, RPK BioPharma Unipessoal, LDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.81%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announces plans to enter the blockchain and artificial intelligence sector of the cannabis industry to enhance supply chain transparency and product authenticity. The Company aims to utilize blockchain technology for certifying genetics, plants, and products, catering to various stakeholders in the cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
AI
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) plans to evaluate strategic investments in the newly legalized German cannabis market, following Germany's recent legalization of recreational cannabis use. The company sees significant growth potential in the region and is considering acquisitions and investments to capitalize on the emerging market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
none
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announces Canmart's integration with META for a seamless social shopping experience on Facebook and Instagram. Canmart, a UK-based medical cannabis company, plans to expand its audience by offering a user-friendly buying experience through shoppable videos. The Company also collaborates with premium suppliers, clinics, and an AI platform to enhance accessibility to medical cannabis products in the UK.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.25%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) strengthens its financial position by selling its Portuguese subsidiary RPK to SOMAÍ Pharmaceuticals for $2 million in cash. The buyer also assumes approximately 4 million Euros of debt, enhancing Akanda's financial stability. Akanda continues to expand its presence in the global cannabis market through its UK subsidiary, Canmart, focusing on importing and distributing Cannabis-Based Products for Medicinal use (CBPMs) and developing the Gabriola Green Project in Canada for THC and CBD products production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.25%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (AKAN) announces integration with META for social shopping on Facebook and Instagram, expanding Canmart's reach. Canmart plans to showcase vendor products through shoppable content on social media, enhancing user experience and audience engagement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.29%
Tags
none
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) aims to integrate technology like Bitcoin, Blockchain, and AI into the cannabis industry to address banking challenges, quality control, and supply chain issues. The company plans to leverage cryptocurrencies for banking solutions and blockchain for transparent supply chain management. Additionally, Akanda is exploring AI applications to optimize cannabis strains and customize plant growth. With a strong financial position from a recent public offering, the company intends to expand its global presence through its UK subsidiary Canmart and the Gabriola Green Project in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.29%
Tags
AI
-
Rhea-AI Summary
Akanda Corp. (AKAN) enters into an underwriting agreement with Univest Securities, for a public offering of Common Shares and Pre-Funded Warrants, raising $5,000,000. The net proceeds will be used for various purposes including capital expenditures, working capital, and acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.29%
Tags
-
Rhea-AI Summary
Akanda Corp. announces a firm commitment underwriting agreement with Univest Securities, for a public offering of common shares, estimating gross proceeds of $5,000,000.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.24%
Tags
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announces the sale of its Portuguese subsidiary, RPK BioPharma, to Somai Pharmaceuticals for $2 million. The transaction signifies a commitment to advancing the medical cannabis industry and improving patient access to high-quality treatments. Akanda will strengthen its financial position and focus on its UK subsidiary, Canmart, while expanding operations in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.33%
Tags
none
Akanda Corp

Nasdaq:AKAN

AKAN Rankings

AKAN Stock Data

1.22M
2.21M
14.02%
0.5%
0.02%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United Kingdom
New Romney